ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Garran, Australian Capital Territory

Find clinical trials in Garran, Australian Capital Territory. Discover local research opportunities and treatment options in your area.

27 Active Trials Found in Garran

Showing 27 trials on this page

Page 1 of 2

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT ID: NCT04994717

This clinical trial is studying a new treatment approach for older adults with a type of blood cancer called Philadelphia-negative B-cell precursor acute lymphoblastic leukemia (ALL). The trial com...

Recruiting
Phase: PHASE3 Conditions: Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT ID: NCT06238622

This clinical trial is looking at how well a medication called BI 1015550 works over a longer period for people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). To ...

Recruiting
Phase: PHASE3 Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting
Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT ID: NCT04973605

This clinical trial is studying a new treatment called BGB-11417 for patients with relapsed or refractory multiple myeloma, which is a type of blood cancer. The trial has two parts: the first part ...

Recruiting
Phase: PHASE1 Conditions: Relapsed/Refractory Multiple Myeloma

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT06236438

This clinical trial is studying a new treatment approach for adults with untreated metastatic non-squamous non-small cell lung cancer (NSCLC), which is a serious type of lung cancer. Researchers wa...

Recruiting
Phase: PHASE2 Conditions: Non-Small Cell Lung Cancer

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

NCT ID: NCT06058585

The CAPTIVATE trial is a large international study looking at different treatments for people with chronic kidney disease (CKD). The main goal of this trial is to find the best way to slow down the...

Recruiting
Phase: PHASE3 Conditions: Chronic Kidney Diseases

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT ID: NCT06722235

This clinical trial is studying a medication called mezagitamab to see if it can help adults with chronic primary immune thrombocytopenia (ITP). ITP is a condition where the immune system mistakenl...

Recruiting
Phase: PHASE3 Conditions: Immune Thrombocytopenic Purpura (ITP)

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT ID: NCT05636176

This clinical trial is studying a new treatment called ziltivekimab for people with heart failure who also have inflammation. Heart failure means the heart isn't pumping blood as well as it should,...

Recruiting
Phase: PHASE3 Conditions: Heart Failure

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT ID: NCT06200207

This clinical trial is studying a new medicine called ziltivekimab to see how well it works for people with heart failure and inflammation. Participants in the study will either receive ziltivekima...

Recruiting
Phase: PHASE3 Conditions: Heart Failure, Systemic Inflammation

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

NCT ID: NCT03968393

This clinical trial is looking at whether taking blood-thinning medication (called anticoagulants) can help prevent strokes in patients who have experienced temporary atrial fibrillation (AF) after...

Recruiting
Phase: PHASE4 Conditions: Stroke, Atrial Fibrillation

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT ID: NCT06424288

This clinical trial is studying a new treatment for heart failure. Specifically, it aims to find out if a medication called BI 690517, when taken together with empagliflozin, can help improve sympt...

Recruiting
Phase: PHASE3 Conditions: Heart Failure

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

NCT ID: NCT06128629

The MAGNITUDE trial is a Phase 3 study that is looking at a new treatment called NTLA-2001 for people with a condition called transthyretin amyloidosis with cardiomyopathy (ATTR-CM), which affects ...

Recruiting
Phase: PHASE3 Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Observational Study Protocol: LIVER-R

NCT ID: NCT06252753

The LIVER-R study is a clinical trial aimed at understanding how effective a treatment called durvalumab is for patients with certain types of liver and bile duct cancers. This study will gather in...

Recruiting
Conditions: Hepatobiliary Cancers

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

NCT ID: NCT05651347

This clinical trial is investigating whether melatonin, a natural hormone, can help protect the brain of babies who are not growing properly in the womb, a condition known as fetal growth restricti...

Recruiting
Phase: PHASE3 Conditions: Fetal Growth Retardation, Pregnancy Preterm +1 more

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

NCT ID: NCT04662905

This clinical trial is studying a new way to deliver treatment for chronic pain using a specialized device called the Evoke System. The trial aims to evaluate a closed-loop system that automaticall...

Recruiting
Phase: NA Conditions: Chronic Pain

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT ID: NCT05334368

This clinical trial is studying a new treatment called depemokimab for adults with Hypereosinophilic Syndrome (HES), a condition where the body produces too many eosinophils, a type of white blood ...

Recruiting
Phase: PHASE3 Conditions: Hypereosinophilic Syndrome

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

NCT ID: NCT01320345

The clinical trial titled "The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye" is looking to see if taking 145 mg of fenofibrate daily can help adults with type 1 diabetes who already ...

Recruiting
Phase: PHASE3 Conditions: Type 1 Diabetes Mellitus, Diabetic Retinopathy +1 more

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

NCT ID: NCT06331624

This clinical trial is studying a new medication called GRI-0621 to see if it can help patients with Idiopathic Pulmonary Fibrosis (IPF), a condition that causes scarring in the lungs and makes it ...

Recruiting
Phase: PHASE2 Conditions: Idiopathic Pulmonary Fibrosis, IPF

Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial

NCT ID: NCT06771050

The ROADMAP Trial is a research study focused on finding the best ways to treat infections that occur in artificial joints, specifically in the hip and knee. The study aims to compare different typ...

Not yet recruiting
Phase: PHASE4 Conditions: Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee +1 more

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

NCT ID: NCT03860883

The Melanoma Margins Trial-II is studying the best surgical approach for adult patients with stage II cutaneous melanoma, which is a type of skin cancer. The trial compares two different widths of ...

Recruiting
Phase: NA Conditions: Cutaneous Melanoma, Stage II
Search All Trials Browse All Locations